BCL2 and neoplasm: This system, based on a magnetothermal nanoparticle platform, utilizes the mild thermal effect (42°C) generated by an alternating magnetic field to activate the CRISPR-Cas9 system, thereby precisely targeting the HSP70 and BCL2 genes and significantly enhancing tumor cell apoptosis (130).